CD4+ Tregs promote cardiomyocyte regeneration by regulating the MRG15/TIP60/CCND1 signaling pathway, offering a new potential target for cardiac regenerative therapy.
Hu et al. (Wed,) conducted a editorial in Cardiovascular disease. CD4+ Tregs / MRG15 was evaluated. CD4+ Tregs promote cardiomyocyte regeneration by regulating the MRG15/TIP60/CCND1 signaling pathway, offering a new potential target for cardiac regenerative therapy.